News

Opthea's Upcoming Presentations at Investment Conferences

Opthea's Upcoming Presentations at Investment Conferences

Opthea's Upcoming Presentations at Investment Conferences

Opthea Limited (ASX/NASDAQ: OPT) is a leading biopharmaceutical company located in Australia, dedicated to developing cutting-edge treatments for prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD). This September, the company is preparing for important engagements with investors, where it will present its latest advancements at two significant conferences.

H.C. Wainwright 26th Global Investment Conference

Opthea will be presenting at the H.C. Wainwright 26th Annual Global Investment Conference. This presentation is scheduled for Monday at 7:00 AM ET, and will be led by Frederic Guerard, PharmD, the CEO of Opthea. This conference provides an excellent opportunity for Opthea to showcase its innovative therapies and discuss the latest progress in treatment options for retinal diseases.

Cantor 2024 Global Healthcare Conference

After the first conference, Opthea will also take part in the Cantor 2024 Global Healthcare Conference, where another presentation is set for Tuesday at 8:35 AM ET. Once again, Frederic Guerard will lead the discussion, highlighting Opthea's dedication to tackling ocular diseases with new therapeutic strategies.

Accessing the Presentations

Both presentations will be accessible for live viewing through webcasts. Interested investors can tune in via the designated channels provided by Opthea, allowing them to catch the latest insights and forecasts from the company's management team.

About Opthea and Its Innovations

Opthea stands out as a biopharmaceutical company that is committed to addressing unmet medical needs in the treatment of progressive retinal diseases. Its leading product candidate, sozinibercept, is currently under evaluation in two important Phase 3 clinical trials. These trials aim to determine the effectiveness of sozinibercept when used alongside existing anti-VEGF therapies, with the goal of improving treatment outcomes for patients experiencing vision impairment due to retinal diseases.

The results expected from these trials could potentially transform care standards and enhance the quality of life for many individuals affected by retinal diseases. By actively engaging with the investment community, Opthea aims to promote transparency and generate interest in its pioneering therapeutic developments.

Frequently Asked Questions

What is the main focus of Opthea's research?

Opthea focuses on developing innovative therapies for retinal diseases, particularly wet age-related macular degeneration and diabetic macular edema.

Who will be presenting at the conferences?

Frederic Guerard, PharmD, the CEO of Opthea, will be the presenter at both conferences.

When are the conferences taking place?

The H.C. Wainwright conference is on September 9, 2024, and the Cantor conference is on September 17, 2024.

How can investors access the presentations?

Investors can access the presentations through webcasts available on the Opthea website.

What is sozinibercept?

Sozinibercept is Opthea's lead product candidate, being investigated in Phase 3 trials to improve patient outcomes when combined with standard anti-VEGF therapies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Solar Fencing Revolutionizes North Texas Homes

Updated Category News Views 4

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 15

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
ScholarShare 529 Launches $50 Back-to-School Promo

Updated Category News Views 4

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Continue Reading
BMAP Expands: Bridging Borders in Legal Advocacy

Updated Category News Views 6

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...

Continue Reading
Rosewood HK Tops Best Hotel List Again; Asia Shines

Updated Category News Views 4

Holding the Crown: Rosewood Hong Kong's Triumph When a single hotel keeps nabbing the top spot in the world's most prestigious rankings, it's worth taking a closer look. That's exactly what's happening with Rosewood Hong Kong, crowned the world's best once more in 2026—its second consecutive year at the pinnacle according to The 50 Best Hotels. Defining Luxury on a...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 3

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 4

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 8

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading
Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 5

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 3

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Employee Productivity Through Modern Office Amenities

Updated Category News Views 174

Exploring the Disconnect Between Office Amenities and Employee Needs As companies strive to create optimal work environments, understanding employee priorities in office amenities has become essential. Recent findings highlight disparities between what organizations provide and what employees prioritize. This misalignment could significantly influence productivity and...

Continue Reading
Quoin Pharmaceuticals Secures Major Funding Boost: Details Inside

Updated Category News Views 229

Quoin Pharmaceuticals Secures Significant Financing Quoin Pharmaceuticals Ltd – ADR (NASDAQ: QNRX) has recently seen a remarkable increase in its stock price as investors respond positively to the announcement of a private placement financing reaching up to $104.5 million. The initial agreement with both new and existing institutional investors includes an upfront...

Continue Reading
Concerns Arise Over Judicial Practices Impacting Senegal's Investment

Updated Category News Views 172

Judicial Irregularities in Senegal's Legal System Khadim Ba, a Non-Executive Director at DerMond Oil & Gas, has become a focal point for concerns regarding the judicial system in Senegal. Detained for months, his situation has attracted the attention of legal experts and rights advocates highlighting serious gaps in due process that threaten both human rights and investor...

Continue Reading
interface.ai Welcomes Steve Swanston: A New Era Begins

Updated Category News Views 171

interface.ai Strengthens Its Leadership Team interface.ai, a forefront player in AI innovation for financial services, has recently announced the appointment of Steve Swanston as its new Chief Revenue Officer (CRO). This significant move is aimed at enhancing the company’s mission to transform the banking landscape through advanced Agentic AI technology. Steve Swanston:...

Continue Reading
Baijiayun Honored for Innovative AI Education Product Excellence

Updated Category News Views 43

Overview of the Award Recognition Baijiayun Group Ltd, often referred to simply as Baijiayun, recently achieved a significant milestone by receiving the "2024 Technological Innovative Educational Product" award. This recognition reflects the company's commitment to technological advancement within the educational sector, particularly through artificial intelligence (AI)...

Continue Reading